Baohong Alice Tian
About Baohong Alice Tian
Baohong Alice Tian is the Senior Director of Non-Clinical Development at BeiGene, where she leads the toxicology program for oncology drug development.
Title
Baohong Alice Tian holds the position of Senior Director of Non-clinical Development at BeiGene.
Company
Baohong Alice Tian is currently employed at BeiGene, a biotechnology company specializing in molecularly targeted and immuno-oncology drugs, where she works in Cambridge, Massachusetts, United States.
Previous Experience
Baohong Alice Tian has extensive experience in drug development and toxicology. She worked as VP of Drug Development at Bl Pharma for one year from 2012 to 2013. Prior to that, she served as Deputy Facility Manager at Joinn Laboratories from 2009 to 2012 in Richmond, California. In 2008, she held a position as Study Director at Mpi Research in Mattawan, Michigan, for three months. From 2001 to 2008, she was a Supervisor and Study Director at Southern Research Institute in Birmingham, Alabama.
Education and Expertise
Baohong Alice Tian holds a Doctor of Philosophy (PhD) in Pharmacology from the University of Georgia. She also earned a Master of Science (MSc) in Pharmacology from an unspecified institution and a Doctor of Medicine (MD) from Beijing Medical College. Her educational background underpins her extensive experience in non-clinical development and toxicology.
Non-clinical Development at BeiGene
Since joining BeiGene in 2013, Baohong Alice Tian has been leading the toxicology program, focusing on both small and large molecule oncology drug development. She is responsible for Investigational New Drug (IND) and New Drug Application (NDA) submissions for novel oncology drugs.